Professor Claire Harrison gives her opinion on whether pregnancy is taken into account often enough when managing female patients with a myeloproliferative neoplasm.
Sorry, all items are required!
Yes, I'm a healthcare professional & I have read and agreed to the Shire Privacy & Cookies Policy
© 2017 Shire
April 2017 - INTSP/C-ANPROM/INT//0092
© 2016 Shire September 2016 - INTSP/C-APROM/XAG/16/0013u